Total Payments
$18,334
2024 Payments
$5,821
Companies
6
Transactions
64
Medicare Patients
205
Medicare Billing
$37,231
Payment Breakdown by Category
Consulting$9,114 (49.7%)
Other$3,888 (21.2%)
Travel$3,860 (21.1%)
Food & Beverage$1,344 (7.3%)
Education$130.08 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,114 | 7 | 49.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,888 | 5 | 21.2% |
| Travel and Lodging | $3,860 | 15 | 21.1% |
| Food and Beverage | $1,344 | 27 | 7.3% |
| Education | $130.08 | 10 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $12,473 | 37 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $3,398 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $2,177 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $200.00 | 1 | $0 (2024) |
| Genentech USA, Inc. | $62.34 | 1 | $0 (2021) |
| Sandoz Inc. | $23.94 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,821 | 19 | United Therapeutics Corporation ($4,146) |
| 2023 | $4,284 | 21 | Merck Sharp & Dohme LLC ($2,136) |
| 2022 | $3,418 | 10 | United Therapeutics Corporation ($3,418) |
| 2021 | $4,811 | 14 | United Therapeutics Corporation ($4,749) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Consulting Fee | Cash or cash equivalent | $1,025.00 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Travel and Lodging | In-kind items and services | $324.90 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $39.44 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | United Therapeutics Corporation | TYVASO (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $48.34 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 08/17/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.12 | General |
| 07/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Cardiology | ||||||
| 06/19/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Consulting Fee | Cash or cash equivalent | $2,730.00 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/07/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Travel and Lodging | Cash or cash equivalent | $68.61 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/07/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $53.69 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/07/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $49.50 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/07/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $49.50 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/07/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/07/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/06/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Travel and Lodging | In-kind items and services | $350.09 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 06/06/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $125.75 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 05/24/2024 | United Therapeutics Corporation | REMODULIN (Drug) | Travel and Lodging | In-kind items and services | $626.18 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 12/14/2023 | Sandoz Inc. | TREPROSTINIL (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PULMONARY ARTERIAL HYPERTENSION | ||||||
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,560.00 | General |
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $42.95 | General |
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| 12/11/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $17.55 | General |
| 10/16/2023 | United Therapeutics Corporation | REMODULIN (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 33 | 73 | $30,890 | $8,695 |
| 2022 | 1 | 44 | 90 | $38,250 | $10,551 |
| 2021 | 1 | 49 | 79 | $28,615 | $9,931 |
| 2020 | 3 | 79 | 99 | $28,875 | $8,054 |
Total Patients
205
Total Services
341
Medicare Billing
$37,231
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 73 | $30,890 | $8,695 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 90 | $38,250 | $10,551 | 27.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 79 | $28,615 | $9,931 | 34.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 31 | 39 | $13,455 | $3,929 | 29.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 45 | $11,565 | $2,963 | 25.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 12 | 15 | $3,855 | $1,162 | 30.2% |
About Mary Whittenhall
Mary Whittenhall is a Acute Care healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205231081.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Whittenhall has received a total of $18,334 in payments from pharmaceutical and medical device companies, with $5,821 received in 2024. These payments were reported across 64 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($9,114).
As a Medicare-enrolled provider, Whittenhall has provided services to 205 Medicare beneficiaries, totaling 341 services with total Medicare billing of $37,231. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Other Specialties Gerontology
- Location Riverside, RI
- Active Since 10/23/2014
- Last Updated 06/17/2024
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1205231081
Products in Payments
- REMODULIN (Drug) $4,565
- OPSUMIT (Drug) $3,376
- ORENITRAM (Drug) $943.27
- TYVASO (Drug) $894.01
- Adempas (Drug) $200.00
- Xofluza (Drug) $62.34
- TREPROSTINIL (Drug) $23.94
- UPTRAVI (Drug) $21.86
- WINREVAIR (Biological) $16.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Riverside
Kelly Owen
Acute Care — Payments: $12,439
Acute Care $12,439
Helia Wilmott, Nurse Practitioner, NURSE PRACTITIONER
Acute Care — Payments: $1,173
Acute Care $1,173
Samuel Marino, Np, NP
Acute Care — Payments: $844.32
Acute Care $844.32
Lorena Ruiz, Ag-Acnp, AG-ACNP
Acute Care — Payments: $832.39
Acute Care $832.39
Hong Tran, Np, NP
Acute Care — Payments: $752.48
Acute Care $752.48
Mrs. Veronica Delgado, Np, NP
Acute Care — Payments: $298.83
Acute Care $298.83